Abbisko Therapeutics collaborates with Lilly to discover novel molecules
January 18, 2022Manufacturing and Production
Abbisko Therapeutics announced that it has entered into a partnership and exclusive licensing agreement with Eli Lilly and Company. This …
Neurimmune and Ono Pharmaceutical collaborate to research neurodegenerative diseases
January 17, 2022Sales and Marketing
Neurimmune AG has signed an expanded drug discovery collaboration agreement with Ono Pharmaceutical. The companies aim to focus on creating …
NICE draft guidance recommends new treatment for rare liver condition
January 17, 2022Sales and Marketing
On Friday 14 January, NICE published a final draft Highly Specialised Technologies guidance, recommending odevixibat in line with its marketing …
FDA places Alzheimer’s therapeutic IND Application on hold
January 17, 2022Sales and Marketing
The FDA has placed a hold on the Investigational New Drug (IND) application for DNL919, indicating they will provide an …
COVID-19 self-isolation cut to five full days in England
January 17, 2022Sales and Marketing
The minimum self-isolation period for people testing positive for COVID-19 in England has been cut from seven days to five …
AstraZeneca and Scorpion strike $1.5bn deal against hard-to-treat proteins
January 14, 2022Medical Communications
AstraZeneca and Scorpion have partnered to develop precision medicines against previously hard-to-target cancer proteins. The collaboration, valued at more than …
South Africa study shows J&J booster 85% effective against Omicron hospitalisation
January 14, 2022Medical Communications
The head of South Africa’s Medical Research Council (SAMRC) has revealed that a J&J booster shot is 85% effective in …
First melanoma test to offer reassurance of low risk of cancer spread
January 14, 2022Medical Communications
A new test reliably predicting the spread or return of the most deadly form of skin cancer has been developed …
WHO recommend two new COVID-19 treatments
January 14, 2022Medical Communications
WHO approved two new treatments for COVID-19 on 14 January, as Omicron cases continue globally, and WHO predicting half of …
Benevolent AI and AstraZeneca expand collaboration on heart failure and systemic lupus discovery
January 13, 2022Business Services
Leading clinical stage AI drug discovery company, Benevolent AI, has expanded its AI-driven drug discovery collaboration with AstraZeneca. This means …
Abivax receive EMA scientific advice support for ulcerative colitis trial
January 13, 2022Business Services
Abivax have received scientific advice from the EMA supporting advancing ABX464 into Phase III clinical testing, for the treatment of …
Antifungal Cresemba (isavuconazole) approved for aspergillosis patients in China
January 13, 2022Business Services
Basilea Pharmaceutica, announced that its license partner, Pfizer, has received a Drug Approval License from the National Medical Products Administration …
PCN-101 R-ketamine Programme receives FDA Investigational New Drug clearance
January 13, 2022Business Services
The FDA has given Investigational New Drug (IND) clearance to atai Life Sciences, to conduct a clinical DDI study of …
White House announces plans to double COVID-19 tests for schools
January 12, 2022Research and Development
The Biden administration announced new plans to increase COVID-19 protection in schools in the US, as the Omicron variant continues …
South Korea Ministry of Food and Drug Safety approves Novavax COVID-19 vaccine
January 12, 2022Research and Development
Biotechnology company Novavax, alongside SK bioscience, a vaccine business subsidiary of Korea-based SK Group, announced that South Korea’s Ministry of …
WHO experts warn against repeated boosters as strategy against COVID-19
January 12, 2022Research and Development
Repeating booster doses of the original COVID-19 vaccines is not a viable strategy against emerging variants, WHO has shared, predicting …
MHRA Approves Vertex’s Kaftrio combination with ivacaftor for Children With cystic fibrosis
January 12, 2022Research and Development
Vertex Pharmaceuticals have announced the MHRA approval of the label extension of Kaftrio® (ivacaftor/tezacaftor/elexacaftor) in a combination regimen with ivacaftor, …
Latest study shows positive results of CanSinoBIO’s inhaled COVID-19 vaccine as booster
January 11, 2022Manufacturing and Production
CanSino Biologics has announced that a heterologous booster with one dose of the Inhalation Convidecia for adults aged 18 years …
Novartis to seek FDA Emergency Use Approval approval for new COVID-19 therapy
January 11, 2022Manufacturing and Production
Novartis shared on the 10 January, that positive data from a clinical trial of COVID-19 therapeutic drug ensovibep, has prompted …
Largest Phase III hemophilia trial produces positive results
January 11, 2022Manufacturing and Production
BioMarin Pharmaceutical has revealed positive results from its ongoing Phase III GENEr8-1 trial on the viability of valoctocogene roxaparvovec as …
Latest content
